Alira Health announced its role as strategic advisor to Mérieux Equity Partners and Mérieux Participations 3 for entering the capital of CTRS

Alira Health announced its role as strategic advisor to Merieux Equity Partners and Mérieux Participations 3 for entering the capital of CTRS, a French pharmaceutical company specialized in the development and commercialization of high added value medical products, with expertise in rare diseases.

We are proud of our partnership with Merieux Equity Partners, a global asset manager specialized within the healthcare & nutrition sectors, based in Lyon, France.

For more information, contact Joris Pezzini.